Delivery Order SPE2DB25D7056-SPE2DB25FTMHX

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,477.66, is for the supply of 4,568,175,921 units of Ambien CR 12.5 mg tablets. The contract has a period of performance through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,202.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ambien CR 6.25 mg tablets and has an ultimate completion date of April 29, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,724.91, is for the delivery of Ambien CR 12.5 mg tablets. The award has an ultimate completion date of November 7, 2024, and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,450.49, is for the delivery of Ambien CR 6.25 mg tablets. The order falls under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the government to procure a comprehensive range of medical commodities, including pharmaceuticals, to support military healthcare...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,617.84 firm fixed-price delivery order is for the supply of Ambien CR 6.25 mg tablets. This order is part of AmerisourceBergen's $999,999,999 IDC with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,082.73 firm fixed-price delivery order is for AMBIEN CR 6.25 MG TABLET 100S and has a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 6.25 mg tablets. The contract has a firm fixed price of $1,190.57 and an ultimate completion date of August 21, 2024. It is not a set-aside contract. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,375.60 firm-fixed-price contract is for the supply of Ambien CR 6.25 mg tablets. The ultimate completion date is September 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical to provide a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Ambien CR 6.25 mg tablets. The $2,307.33 firm fixed-price contract has a completion date of September 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities. The company has...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication, with a ceiling value of $2,267.44 and a performance period ending on August 16, 2024. The contract is a firm-fixed-price, non-set-aside vehicle. AmerisourceBergen, through its extensive federal contracting experience and logistics...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTMHX
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,163,597 units of Ambien CR 6.25 mg tablets, with a firm fixed price of $3,303.66 and a period of performance through May 8, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/6/25, 10:00 AM